C4 Therapeutics Inc
(CCCC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 76,124 | 162,745 | 281,146 | 94,912 | 181,727 |
| Marketable Securities | 233,155 | 239,326 | 184,765 | 218,567 | 189,962 |
| Receivables | 5,716 | 4,845 | 6,213 | 3,656 | 4,484 |
| TOTAL | $325,689 | $412,294 | $477,561 | $322,011 | $381,009 |
| Non-Current Assets | |||||
| PPE Net | 3,108 | 3,323 | 3,653 | 4,015 | 3,323 |
| Investments And Advances | 142,200 | 78,191 | 32,770 | 32,495 | 0 |
| Other Non-Current Assets | 35,768 | 14,103 | 14,437 | 15,486 | 15,806 |
| TOTAL | $181,076 | $95,617 | $50,860 | $51,996 | $19,129 |
| Total Assets | $506,765 | $507,911 | $528,421 | $374,007 | $400,138 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,506 | 3,745 | 4,469 | 3,742 | 5,683 |
| Accrued Expenses | 13,606 | 11,471 | 9,871 | 6,260 | 9,524 |
| TOTAL | $51,246 | $48,687 | $44,166 | $37,653 | $43,852 |
| Non-Current Liabilities | |||||
| Long Term Debt | 10,768 | 10,588 | 10,409 | 10,231 | 10,052 |
| Deferred Revenues | 31,800 | 32,294 | 28,695 | 26,565 | 27,603 |
| Other Non-Current Liabilities | 30,777 | 10,920 | 11,230 | 11,532 | 11,826 |
| TOTAL | $65,913 | $60,444 | $67,828 | $72,649 | $75,495 |
| Total Liabilities | $117,159 | $109,131 | $111,994 | $110,302 | $119,347 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 48,739 | 48,626 | 48,454 | 43,195 | 43,119 |
| Common Shares | 5 | 5 | 5 | 4 | 4 |
| Retained earnings | -267,715 | -252,057 | -227,374 | -204,794 | -183,823 |
| Other shareholders' equity | -775 | -155 | -69 | -94 | 13 |
| TOTAL | $389,606 | $398,780 | $416,427 | $263,705 | $280,791 |
| Total Liabilities And Equity | $506,765 | $507,911 | $528,421 | $374,007 | $400,138 |